News

BlockBeats News, June 30, Rocket Lab announced on Monday that it will acquire satellite communications service provider Iridium Communications (IRDM.O) for approximately $8 billion, with the transaction expected to be completed by mid-2027. Iridium Communications shareholders will receive $27 per share in cash and company stock, with a total value of $54 per share, representing a 24.1% premium over the previous trading day. This acquisition will integrate Rocket Lab's launch and satellite manufacturing business with Iridium Communications' global L-band satellite network, licensed spectrum resources, and over 2.5 million government, defense, aviation, maritime, and commercial customers, allowing it to form a vertically integrated model similar to SpaceX and Starlink. This is Rocket Lab's fourth acquisition this year, and analysts believe that the transaction will immediately provide the company with a mature customer base and distribution network, whose value may exceed that of the hardware and spectrum resources themselves. To finance the cash portion, the company has secured $3.6 billion in bridge loan commitments from Deutsche Bank and JPMorgan. It is worth noting that this deal comes as SpaceX completed an $86 billion IPO earlier this month, further expanding its satellite communications and AI infrastructure business, with SpaceX also having previously reached an agreement to acquire EchoStar's spectrum resources. Amidst the wave of consolidation in the aerospace industry, Rocket Lab is attempting to challenge SpaceX's leading position in the satellite communications field with a closed-loop "launch + satellite network" layout.

Golden Ten Data reported on June 30 that recently, JinkoSolar and a Greek clean energy developer officially signed a 282.45MW high-efficiency module supply agreement. The entire project will utilize Tiger Neo 3.0 N-type TOPCon high-efficiency bifacial modules, which are dedicated to the construction of large-scale ground power stations in the region.

Mr. Garland has extensive leadership experience in the biotechnology industry, and his appointment is expected to bring strategic vision to the board of directors. Meanwhile, Mr. Lisgarten will be responsible for the company's legal affairs and compliance management, strengthening the corporate governance structure. These senior management changes mark the company's efforts to reinforce its governance team to support future business development.